A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway

<div>(a) X-ray diffractogram of the ruthenium-fluvastatin complex. Scanning electron microscopy (SEM) of the complex at (b) 200 <i>μ</i>m (c) 100 <i>μ</i>m, and (d) 50 <i>μ</i>m.</div>

Oxidative Medicine and Cellular Longevity

fig4

Figure 4

Figure 4: A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway 

Figure 4 | A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway 